Healthcare Services

A Significant Growth Driver for the Monocyte Activation Test Market Is the Growing Incidence Of Autoimmune Disorders Fueling The Growth Of The Market Due To Rising Immune Dysregulation From Environmental Pollutants

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Monocyte Activation Test Market Between 2026 And 2030?

The monocyte activation test market has experienced significant expansion in recent years. It is forecast to grow from $0.54 billion in 2025 to $0.63 billion in 2026, progressing at a compound annual growth rate (CAGR) of 14.9%. This past growth in the historic period is attributable to increasing biologics development activities, greater regulatory scrutiny concerning pyrogen safety, the shift away from animal-based testing methods, the broader scope of pharmaceutical quality control testing, and rising investment in in vitro testing technologies.

The monocyte activation test market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $1.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.6%. This projected growth during the forecast period stems from factors such as the greater acceptance of sophisticated biologics and vaccines, an increased need for efficient safety testing, the proliferation of automated laboratory procedures, rising governmental encouragement for non-animal testing methods, and the expanding incorporation of digital laboratory platforms. Key developments expected within this period encompass a wider embrace of animal-free pyrogen testing, an uptick in the deployment of automated MAT assay systems, a deepening integration of data management software, the broadening availability of GMP-compliant testing solutions, and a heightened emphasis on the regulatory approval of MAT.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24610&type=smp

What Key Drivers Are Influencing The Growth Of The Monocyte Activation Test Market?

The monocyte activation test market is anticipated to expand due to the increasing occurrence of autoimmune disorders, which are conditions where the body’s immune system mistakenly attacks its own healthy cells instead of defending against foreign invaders. The rising prevalence of these disorders largely stems from greater exposure to pollutants that disturb immune regulation and trigger abnormal responses. The monocyte activation test (MAT) provides a dependable way to assess immune system activation, aiding in the detection of autoimmune disorders. It assists in identifying atypical immune responses, which is vital for diagnosing conditions like lupus and rheumatoid arthritis, thereby enhancing early detection and management. For example, Arthritis Australia, an Australia-based non-profit organization, estimated in February 2024 that 562,378 Australians will have RA in 2025, making up 14% of all arthritis cases that year. This figure is projected to climb by 33% to 748,721 people by 2040, marking an increase of 186,343 Australians with RA compared with 2025. Consequently, the rising frequency of autoimmune disorders is fueling the growth of the monocyte activation test market. Monocyte Activation Test Market Driver: Rise In Healthcare-Associated Infections Driving Market Expansion Due To Growing Need For Advanced Infection Control Solutions

Which Market Segments Are Examined In The Monocyte Activation Test Market Study?

The monocyte activation test market covered in this report is segmented –

1) By Product Type: Reagents, Test Kits, Assay Systems, Software Solutions

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Polymerase Chain Reaction (PCR), Luminex Technologies

3) By Distribution Channel: Direct Sales, Distributors Or Third-party Partners, Online Retailers, Institutional Sales

4) By Application: Drug Development, Vaccine Development, Medical Device Testing, Other Applications

5) By End-User: Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Hospitals And Laboratories

Subsegments:

1) By Reagents: Endotoxin Standards, Cytokine Detection Reagents, Cell Culture Media, Limulus Amebocyte Lysate (LAL) Reagents, Blocking Agents And Buffers

2) By Test Kits: Quantitative Monocyte Activation Test Kits, Qualitative Monocyte Activation Test Kits, Good Manufacturing Practice (GMP)-Compliant Test Kits, Endotoxin-Specific Test Kits, Pyrogen Detection Kits

3) By Assay Systems: Benchtop Monocyte Activation Analyzers, Automated High-Throughput Systems, Microplate Readers, Cell Imaging Systems, Flow Cytometry-Based Systems

4) By Software Solutions: Data Analysis Software, Laboratory Information Management Systems (LIMS) Integration Tools, Compliance And Audit Trail Software, Remote Monitoring And Control Software, Real-Time Result Interpretation Tools

What Key Developments And Trends Are Impacting The Monocyte Activation Test Market?

Leading companies in the monocyte activation test market are prioritizing the development of technologically advanced monocyte activation test (MAT) products, such as pyrogen and endotoxin tests, to improve test sensitivity and better detect immune responses. These pyrogen and endotoxin tests are employed to identify substances capable of inducing fever, especially endotoxins from gram-negative bacteria. A notable example occurred in June 2024, when FUJIFILM Wako Pure Chemicals Corporation, a chemical manufacturer from Japan, unveiled the LumiMAT Pyrogen Detection Kit, a next-generation monocyte activation test for in vitro pyrogen screening, alongside PYROSTAR Neo+, a recombinant protein reagent designed for detecting bacterial endotoxins. These specific products significantly enhance the accuracy, efficiency, and safety of pyrogen testing within the pharmaceutical and biotechnology sectors.

Who Are The Primary Competitors In The Monocyte Activation Test Market?

Major companies operating in the monocyte activation test market are Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Lonza Group, Charles River Laboratories, Nelson Laboratories LLC, Solvias AG, Labor LS SE and Co. KG, BMG Labtech, Cellular Technology Limited, Creative Biolabs, FUJIFILM Wako Chemicals, Microcoat Biotechnologie GmbH, MAT BioTech B.V., Sanquin Diagnostiek B.V., PyroDex LLC, MAT Research B.V., Minerva Biolabs GmbH, Wickham Micro Limited, Rapid Test Methods Ltd.

Read the full monocyte activation test market report here:

https://www.thebusinessresearchcompany.com/report/monocyte-activation-test-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Monocyte Activation Test Market?

North America was the largest region in the monocyte activation test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monocyte activation test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Monocyte Activation Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24610&type=smp

Browse Through More Reports Similar to the Global Monocyte Activation Test Market 2026, By The Business Research Company

Monkey Pox Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Zoonotic Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Sheep And Goat Pox Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/sheep-and-goat-pox-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795